These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1774443)

  • 21. Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
    Jenkins PJ; Jain A; Jones SL; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):447-51. PubMed ID: 8959084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia.
    Ciccarelli E; Miola C; Avataneo T; Camanni F; Besser GM; Grossman A
    Fertil Steril; 1989 Dec; 52(6):930-5. PubMed ID: 2591571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The therapy of a macroprolactinoma with the intramuscular application of a long-acting bromocriptine preparation].
    Kreft B; Peters A; Kerner W
    Dtsch Med Wochenschr; 1996 Jul; 121(27):865-8. PubMed ID: 8681742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of hyperprolactinemia with pergolide.
    Mattox JH; Bernstein J; Buckman MT
    Int J Fertil; 1986; 30(4):39-43. PubMed ID: 2890594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
    Höfle G; Gasser R; Mohsenipour I; Finkenstedt G
    Exp Clin Endocrinol Diabetes; 1998; 106(3):211-6. PubMed ID: 9710362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
    López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
    Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin excess: treatment and toxicity.
    Gillam MP; Fideleff H; Boquete HR; Molitch ME
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():108-14. PubMed ID: 16456489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary treatment of macroprolactinomas with Parlodel LAR.
    van 't Verlaat JW; Lancranjan I; Hendriks MJ; Croughs RJ
    Acta Endocrinol (Copenh); 1988 Sep; 119(1):51-5. PubMed ID: 3414319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shrinkage of pituitary PRL-secernent adenoma after short-term treatment with bromocriptine long-acting repeatable injections.
    Paoletti AM; Cagnacci A; Mais V; Ajossa S; Guerriero S; Murgia C; Depau GF; Serra GG; Melis GB
    Clin Exp Obstet Gynecol; 1994; 21(2):124-8. PubMed ID: 8070116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability, safety and efficacy of two formulations of Parlodel--a slow release oral form (SRO) versus registered Parlodel capsules.
    Biberoğlu K; Atasü T; Shabgahi B; Kandemir O
    Gynecol Obstet Invest; 1994; 37(1):6-9. PubMed ID: 8125413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Short-term effect of delayed-action injectable bromocriptine in macroprolactinoma. French multicenter study].
    Brue T; James-Deidier A; Louvet JP; Dewailly D; Roger P; Schlienger JL; Schaison G; Hartemann P; Jaquet P
    Ann Endocrinol (Paris); 1991; 52(4):273-82. PubMed ID: 1818531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical treatment of prolactin and growth hormone-secreting pituitary tumors].
    Jadresic A
    Rev Med Chil; 1997 Nov; 125(11):1383-8. PubMed ID: 9609063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.
    Abs R; Parizel PM; Beckers A
    J Endocrinol Invest; 1991 Feb; 14(2):135-8. PubMed ID: 1905737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New perspectives in medical management of hyperprolactinemia.
    Montini M; Gianola D; Pagani MD; Tengattini F; Dominoni P; Sileo F; Ferrari L; Stroppa S; Gualteroni L; Pagani G
    Endocrinol Exp; 1990 Mar; 24(1-2):159-66. PubMed ID: 2361458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and tolerability of CV 205-502 (a nonergot dopaminergic drug) in macroprolactinoma patients and in prolactinoma patients intolerant to bromocriptine.
    van der Lely AJ; Brownell J; Lamberts SW
    J Clin Endocrinol Metab; 1991 May; 72(5):1136-41. PubMed ID: 1673685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.